Clinical trial · Observational
QPlus Pediatric Reference Interval
Evaluation of a Pediatric Reference Interval Using QPLUS System
NCT05645133CI-TRIAL-00067152terminatedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): PI relocated to another institution
Summary
Brief summary (as posted)
Evaluation of coagulation results reported by the Qplus Quantra System to determine pediatric reference range intervals.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Healthy | — | UNRESOLVED | — |
| Pediatric ALL | Childhood Acute Lymphoblastic Leukemia | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Diagnostic Test | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (5)
- measure
- Reference range interval for measurement of clot time (CT) parameter
- timeFrame
- Baseline, after access placement before any procedures
- description
- Reference range interval determined in this study will serve as the reference for CT results in this particular population
- measure
- Reference range interval for measurement of clot time (CTH) parameter
- timeFrame
- Baseline, after access placement before any procedures
- description
- Reference range interval determined in this study will serve as the reference for CTH results in this particular population
- measure
- Reference range interval for measurement of clot stiffness (CS) parameter
- timeFrame
- Baseline, after access placement before any procedures
- description
- Reference range interval determined in this study will serve as the reference for CS results in this particular population
Eligibility
Eligibility (as posted)
- Sex
- All
- Maximum age
- 17 Years
Show eligibility criteria text
Inclusion Criteria: * \<18yrs * Scheduled for procedure requiring anesthesia * Access to blood sampling * Consented Exclusion Criteria: * \>18yrs of age * pre-term babies * patients with know hematological disorders * Difficult to obtain blood sampling * Has received a blood product transfusion within the last 24hrs. * Legal guardian unwilling to consent
References
Publications (0)
Data not yet available
No reference posted for this study.